Edition:
United Kingdom

Simulations Plus Inc (SLP.OQ)

SLP.OQ on NASDAQ Stock Exchange Capital Market

16.50USD
22 Nov 2017
Change (% chg)

$-0.20 (-1.20%)
Prev Close
$16.70
Open
$16.75
Day's High
$16.75
Day's Low
$16.45
Volume
8,328
Avg. Vol
14,135
52-wk High
$17.45
52-wk Low
$8.85

Summary

Name Age Since Current Position

Walter Woltosz

71 2014 Chairman of the Board, Chief Executive Officer

Thaddeus Grasela

62 2014 President, Director

John Kneisel

58 2013 Chief Financial Officer

John DiBella

36 2012 Vice President - Sales & Marketing

Daniel Weiner

67 2017 Director

John Paglia

49 2014 Independent Director

David Ralph

69 2012 Independent Director

Renee Bouche

IR Contact Officer

Biographies

Name Description

Walter Woltosz

Mr. Walter S. Woltosz is Chairman of the Board and Chief Executive Officer of the Company. Mr. WOLTOSZ is a co-founder of the Company and has served as its Chief Executive Officer and as Chairman of the Board since its incorporation in July 1996. He also served as President of the Company until Dr. Grasela was appointed to that office on September 2, 2014. Mr. Woltosz is the husband of Mrs. Woltosz, the Company’s Treasurer and Corporate Secretary, and a former director. Mr. Woltosz’ knowledge of the industry and his 20 years of experience running Simulations Plus makes him a qualified candidate for the Board.

Thaddeus Grasela

Dr. Thaddeus Henry Grasela is President and Director of the Company. Mr. GRASELA has been President and a Director of the Company since the Company acquired Cognigen Corporation (“Cognigen”) also known as the Buffalo Division of the Company, on September 2, 2014. He was the founder, President and Chief Executive Officer of Cognigen for 22 years prior to the acquisition, and continues to serve as its President. Dr. Grasela has had extensive experience in the strategic oversight of scientific consulting projects, promoting new revenue generation, managing profitability, and overseeing the growth of the organization. He is a Fellow of the American Association of Pharmaceutical Scientists and Adjunct Professor in the Department of Pharmaceutical Sciences at the State University of New York at Buffalo. He received his PharmD in 1979 from the Philadelphia College of Pharmacy and Science and his doctorate in Epidemiology from the University at Buffalo in 1999. Dr. Grasela’s knowledge of the pharmaceutical industry and his experience running Cognigen makes him a qualified candidate for the Board.

John Kneisel

Mr. John R. Kneisel CPA is a Chief Financial Officer of Simulations Plus, Inc. Mr. KNEISEL joined the Company in November 2013. Mr. Kneisel worked as the Western Regional Controller of Group 1 Automotive Inc. from August 2004 through October 2009. In November 2009, he started a consulting business providing outsourced financial management services (CFO and Controller) to small- to medium-sized companies. In October 2010, he became the CFO of Dreamhammer, Inc. where he worked until August 2012. At that time he returned full time to his consulting practice until joining the Company. Mr. Kneisel is a certified public accountant. During his time in public accounting, he served as a general business consultant, assisting in the implementation of operation controls as well as providing assurance services to his clients.

John DiBella

Mr. John A. DiBella II serves as the Vice President, Marketing and Sales of Simulations Plus Inc. Mr. DIBELLA joined the Company in June 2003 as a Modeling & Simulations Scientist. In 2005, Mr. DiBella moved to the Marketing and Sales Department, and worked as a Field Scientist. Mr. DiBella took over the Marketing and Sales Department and worked as Director until February 2012. He was appointed Vice President of Marketing and Sales of the Company in March 2012.

Daniel Weiner

Dr. Daniel L. Weiner is Director of the company. He has extensive drug development experience and has served as an expert consultant to the U.S. Food and Drug Administration (FDA) on pharmacokinetic modeling and bioequivalence assessment. Prior to his previous tenure with Certara/Pharsight as a Senior Vice President and Chief Science Officer, Dr. Weiner held several management positions with Merrell Dow Pharmaceuticals; Statistical Consultants, Inc.; Syntex Development Research; Quintiles; and IVAX Research. Dr. Weiner graduated from the University of Kentucky with a doctoral degree in Mathematical Statistics, with emphasis on compartmental modeling. He is the original designer/author of the WinNonlin family of PK/PD Modeling Software now used by over 1,000 institutions. He is the co-author of Pharmacokinetic and Pharmacodynamic Data Analysis: Concepts and Applications, now in its fifth edition. Dr. Weiner is an Adjunct Associate Professor with the Division of Pharmacotherapy and Experimental Therapeutics in the School of Pharmacy, University of North Carolina, and an Affiliate Professor of Pharmacometrics, Center for Translational Medicine in the School of Pharmacy at the University of Maryland.

John Paglia

Dr. John K. Paglia is appointed as a director of the Company. Mr. Paglia was appointed as a Director of the Company as of December 3, 2014. Dr. Paglia holds a Ph.D. in finance, an MBA, a B.S. in finance, and is a Certified Public Accountant and Chartered Financial Analyst. In 2007 he joined the faculty of Pepperdine University, and in 2014 became Associate Dean at the Graziadio School of Business and Management at Pepperdine University. Dr. Paglia leads the design and delivery of evening and weekend business degree programs for working professionals, as well as oversees student recruitment for these programs and the school-wide marketing, communications, and public relations functions. He founded the award-winning Pepperdine Private Capital Markets Project. From 2003 to 2009, Dr. Paglia was the managing director of Paglia Consulting Group, LLC, a business valuation, fina ncial consulting, and litigation support firm.

David Ralph

Dr. David L. Ralph has been appointed as Independent Director of Simulations Plus, Inc. Mr. Ralph has served as a Director of the Company since March 2012. He is currently a Professor of Marketing at Pepperdine University, and has been on the faculty since 1968. He is a member of the Pepperdine 2020 Strategic Planning Committee and the Marketing Task Force. Dr. Ralph also serves as the Chair of the Fully Employed MBA Program Administrative Committee and is a member of the University Faculty Council at Pepperdine. He has consulted with key executives in a wide range of industries on marketing. He also acted as President and Chief Executive Officer of Antelope Valley Christian School from 1986 to 2005. He has served as the Associate Dean of The Graziadio School of Business and Management at Pepperdine University and currently serves as the Chair of the Department of Economics, Law, and Marketing. His business experience, knowledge of business operations, and marketing skills qualify him as a candidate for the Board.

Renee Bouche

Basic Compensation

Name Fiscal Year Total

Walter Woltosz

257,812

Thaddeus Grasela

285,000

John Kneisel

212,215

John DiBella

247,125

Daniel Weiner

--

John Paglia

--

David Ralph

--

Renee Bouche

--
As Of  31 Aug 2016

Options Compensation